SEC Form 4 · accession 0001209191-17-057041
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aron Marc Knickerbocker
Officer — Chief Operating Officer · Director
Period of report
Oct 12, 2017
Accepted (ET)
Oct 16, 2017 · 7:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 12, 2017 | M | 1,396 | $8.49 | A | 161,691 | D | |
| Common Stock | Oct 12, 2017 | M | 9,655 | $7.26 | A | 171,346 | D | |
| Common Stock | holding | — | — | — | 15,083 | I | By the Aron M. Knickerbocker Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $8.49 | Oct 12, 2017 | M | 1,396 | D | — | Jan 1, 2022 | Common Stock | 1,396 | 4,186 | D |
| Employee Stock Option (right to buy)F1 | $7.26 | Oct 12, 2017 | M | 9,655 | D | — | Jul 18, 2023 | Common Stock | 9,655 | 14,735 | D |
Explanation of responses
- F1This option is fully vested and immediately exercisable.